175

Dermatology
Focus on skin health and related diseases.
Sub Categories on Dermatology
Latest Articles
Repurposing FDA-approved drugs may decrease fibrosis in butterfly disease

Repurposing FDA-approved drugs may decrease fibrosis in butterfly disease

by Moriah Cunningham,Thomas Jefferson UniversityMatrix detachment recapitulates fibrotic phenotypes through the TGFβ pathway. Credit:EMBO Molecular Medicine(2024). DOI: 10.1038/s4432

Repurposing FDA-approved drugs may decrease fibrosis in butterfly disease

by Moriah Cunningham,Thomas Jefferson UniversityMatrix detachment recapitulates fibrotic phenotypes through the TGFβ pathway. Credit:EMBO Molecular Medicine(2024). DOI: 10.1038/s4432
Self-guided online treatment can help with atopic eczema

Self-guided online treatment can help with atopic eczema

byKarolinska InstitutetHuman skin structure. Credit: WikipediaA new study from Karolinska Institutet shows that self-guided cognitive behavioral therapy (CBT) online is as effective as psycholog

Self-guided online treatment can help with atopic eczema

byKarolinska InstitutetHuman skin structure. Credit: WikipediaA new study from Karolinska Institutet shows that self-guided cognitive behavioral therapy (CBT) online is as effective as psycholog
Do skin moisturizers help prevent eczema in infants?

Do skin moisturizers help prevent eczema in infants?

by WileyCredit: CC0 Public DomainAtopic dermatitis (AD), also called atopic eczema, is the most common, chronic, recurrent, inflammatory disorder of the skin, and it affects 5–30% of children wor

Do skin moisturizers help prevent eczema in infants?

by WileyCredit: CC0 Public DomainAtopic dermatitis (AD), also called atopic eczema, is the most common, chronic, recurrent, inflammatory disorder of the skin, and it affects 5–30% of children wor
Melanoma risk from biologic therapy remains uncertain

Melanoma risk from biologic therapy remains uncertain

(HealthDay)—Clinically important increases in melanoma risk in patients treated with biologic therapy for common inflammatory diseases cannot be ruled out based on current evidence, according to a rev

Melanoma risk from biologic therapy remains uncertain

(HealthDay)—Clinically important increases in melanoma risk in patients treated with biologic therapy for common inflammatory diseases cannot be ruled out based on current evidence, according to a rev
Scientists develop novel self-healing electronic skin for health monitoring

Scientists develop novel self-healing electronic skin for health monitoring

by Terasaki Institute for Biomedical InnovationCredit: AI-generated imageResearchers have achieved a breakthrough in wearable health technology by developing a novel self-healing electronic skin (E-Sk

Scientists develop novel self-healing electronic skin for health monitoring

by Terasaki Institute for Biomedical InnovationCredit: AI-generated imageResearchers have achieved a breakthrough in wearable health technology by developing a novel self-healing electronic skin (E-Sk
Editorial explores safety, ethics and patient satisfaction of cosmetic dermatology in the digital age

Editorial explores safety, ethics and patient satisfaction of cosmetic dermatology in the digital age

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainDriven by rapid advances in technology and the ever-growing influence of the digital landscape, the art of caring for the p

Editorial explores safety, ethics and patient satisfaction of cosmetic dermatology in the digital age

byBoston University School of MedicineCredit: Pixabay/CC0 Public DomainDriven by rapid advances in technology and the ever-growing influence of the digital landscape, the art of caring for the p
FDA approves Zoryve for atopic dermatitis

FDA approves Zoryve for atopic dermatitis

by Lori SolomonThe U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and p

FDA approves Zoryve for atopic dermatitis

by Lori SolomonThe U.S. Food and Drug Administration has approved Arcutis Biotherapeutics' Zoryve (roflumilast) cream, 0.15%, for the treatment of mild-to-moderate atopic dermatitis in adult and p
Vitiligo: Loss of skin's pigment-producing cells could be related to basement membrane disruption

Vitiligo: Loss of skin's pigment-producing cells could be related to basement membrane disruption

byOsaka Metropolitan UniversityA graphical representation illustrates what might be occurring in undamaged and damaged skin. Credit: Osaka Metropolitan UniversitySkin pigmentation disorders affe

Vitiligo: Loss of skin's pigment-producing cells could be related to basement membrane disruption

byOsaka Metropolitan UniversityA graphical representation illustrates what might be occurring in undamaged and damaged skin. Credit: Osaka Metropolitan UniversitySkin pigmentation disorders affe
Confirmatory testing underused for tinea capitis diagnosis

Confirmatory testing underused for tinea capitis diagnosis

by Lori SolomonConfirmatory laboratory testing is only used in one in five cases of suspected tinea capitis (TC), according to a research letter published in the July issue of theJournal of the

Confirmatory testing underused for tinea capitis diagnosis

by Lori SolomonConfirmatory laboratory testing is only used in one in five cases of suspected tinea capitis (TC), according to a research letter published in the July issue of theJournal of the